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Inflammatory events in the corneal stroma may activate keratocytes and 
trigger their transition towards myofibroblasts, which now produce different 
extracellular matrix (ECM) proteins thus causing corneal opacification. 
Corneal haze is a frequent side effect after photorefractive keratectomy 
(PRK) to correct high myopia. Currently, a preventive treatment with 
mitomycin-c can be used to limit the occurrence of this phenomenon. 
However, mitomycin-c is a toxic drug, not devoid of side effects, which 
may occasionally involve the corneal endothelium. Therefore, we have 
searched for a less risky, natural way, to prevent keratocytes transition. To 
this purpose, we have used as markers of the phenotype switch the proteins 
lumican (highly expressed by keratocytes and much less by myofibroblasts) 
and smooth muscle actin (αSMA) (highly expressed by myofibroblasts 
and poorly found in keratocytes), beside Fibronectin (Fn), the expression 
of which is also increased by transforming growth factor-beta (TGFβ 
treatment. Treatment of human keratocytes with TGFβ was used to induce 
the protein shift. Among different possible candidates, we have found that 
vitamins A and E, hyaluronic and lactobionic acids may prevent, either 
alone, or much better in association, the shift in the ratio between lumican 
and αSMA and the increased Fn expression. In conclusion, it could be 
speculated that topic treatment of the ocular surface with an association 
of these four compounds could be able to prevent or at least limit the 
occurrence of post-PRK corneal haze, with the additional advantage of 









The cornea is the most external tissue of the eye, 
and the main lens of the ocular diopter, accounting 
for approximately 48 diopters [1]. In order to perform 
efficiently its role, the cornea must be highly transparent, 
so that the light arrives undisturbed to the photoreceptors 
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in the retina, with no blurring or distortion of the images. 
Such transparency of the cornea is due to three different 
characteristics of this tissue. (I) The cornea is avascular. 
The pathologic presence of blood vessels in the cornea 
would alter the delicate hydration balance of this tissue, 
and in case blood vessels should invade the area covering 
the pupil, they could shield and deflect the light entering 
the eye. The avascularity of the cornea is maintained 
through the presence of a VEGF-trap molecule, a soluble, 
truncated form of the VEGF receptor-1 (sVEGFR-1) 
the product of the soluble Flt gene [2] (sFlt-1). (II) The 
hydration state of the corneal stroma is optimized for 
transparency, and tightly controlled by the ionic pumps 
of the corneal endothelium [3]. Failure of these pumps, for 
iatrogenic, traumatic or genetic reasons, leads to corneal 
edema and corneal opacification potentially invalidating 
for the patient [4]. (III) Corneal stroma has a special 
architecture that results in a transparent matrix. Collagen 
fibrils are arranged in approximately 200 layers of 
lamellae, each one arranged regularly almost right angle to 
each other [5]. This arrangement, critical for transparency, 
is maintained by proteoglycans such as lumican and 
keratocan [6]. In the case of local inflammatory events, such 
as after PRK, the release by injured epithelial cells of the 
inflammatory cytokine TGFβ induces the transformation of 
keratocytes into myofibroblasts, characterized by a decreased 
production of lumican and an increased expression of the 
cytoskeletal protein αSMA [7,8].
PRK triggers inflammation and a wound healing 
response in the corneal stroma. Keratocytes replicate 
under the influence of TGFβ, and undergo the transition 
towards myofibroblasts, thus causing corneal haze. 
Moreover, regenerating nerve endings after the lesion 
caused by PRK tend to avoid corneal regions populated 
by myofibroblasts [9], so that corneal haze may be 
accompanied by delayed nerve regeneration. Mytomicin 
C is a cytotoxic antibiotic that alkylates DNA and 
proteins, thus inducing apoptosis of proliferating cells. 
The intraoperative use of mytomicin C, by killing 
the replicating keratocytes, has been shown to be 
effective in reducing the risk of haze development [10] 
and delayed nerve regeneration [9] after PRK. Such 
treatment, however, despite being in use since many 
years with no reports of serious complications, is 
not devoid of potential side effects. In a preclinical 
study on rabbits, mitomycin C significantly reduced 
keratocyte density in the anterior stroma, with an 
effect lasting at least 6 months [10]. Such reduction may 
cause biomechanical instability, iatrogenic ectasia and 
increased risk of corneal melting in case of a further 
delay of keratocyte repopulation [11].  Endothelial 
toxicity and endothelial cell loss are other possible side 
effects, putting the patient at risk of corneal edema 
development because of a reduced function of the 
endothelial pump system [12].
Based on this knowledge, we set out to investigate 
whether we could identify some different natural, non-
toxic compounds, which upon topic administration could 
prevent the myofibroblast transition of keratocytes, thus 
reducing the risk of corneal haze development after a 
traumatic corneal injury. In order to obtain an initial proof 
of concept, we have used a primary cell culture of human 
keratocytes, treated with TGFβ to induce the keratocyte 
to myofibroblast transition, monitored by the expression 
of the main determinants characterizing the two states: 
lumican, αSMA and Fn.
2. Materials and Methods
2.1 Cell Culture
Human primary corneal keratocytes (Innoprot, cat. No. 
P10872) have been used throughout the study. Human 
keratocytes (HK) were routinely grown in fibroblast 
medium (Innoprot, cat. No. P60108) with 2% fetal bovine 
serum (FBS) and 5% horse serum (HS), in a humidified 
incubator at 37°C, and 5% CO2. HK from the original 
vial were expanded to generate freezing lots considered at 
passage 2. Freshly thawed cultures were normally splitted 
by trypsinization at 1/3 dilution for no more than 10 
passages (roughly 15 population doublings). 
2.2 Cell Treatment
Trypsinized cells from semi-confluent cultures were 
seeded in 6 multiwell plates at a cell density of 5000/cm2 
in growth medium. The next day, wells were rinsed with 
PBS, and cells shifted 4 hours to serum free fibroblast 
medium. A further 3-hour pre-incubation followed, with 
50 μM vitamin E (Sigma-Aldrich Cat. No.258024), 10 
μM retinyl palmitate (Sigma-Aldrich Cat. No. PHR1235), 
2% w/v sodium lactobionate (SL) (Glentham Life 
Science, Wiltshire, United Kingdom Cat. No. GK2515), 
0.15% w/v hyaluronic acid (HA) (MW 1.5 MDa) (kindly 
supplied by SOOFT Italia SpA, Montegiorgio, Italy) 
prepared at the indicated final concentrations, either alone 
or in association. Then, TGFβ1 (R&D Systems, United 
Kingdom Cat. No. 240-B-002) was added at 10 ng/ml, 
and plates incubated for further 48 hours. At the end of 
the incubation period, cell monolayers were rinsed three 
times with PBS and extracted with RIPA (Calbiochem-
Merck, Darmstadt, Germany, Cat. No. 20188) in presence 
of protease inhibitors (Protease Inhibitor Cocktail Set III 
EDTA-Free, Calbiochem-Merck, Darmstadt, Germany, 
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Cat. No. 539134) for 30 minutes on ice. Extracts were 
then clarified by centrifugation at 13000 rpm for 20 
minutes at 4°C, and proteins in supernatants quantified by 
the BCA assay (Sigma-Aldrich, Cat. No. 2322). 
2.3 Western Blotting
Thirty µg of proteins were then loaded on a pre-casted 
4-12% SDS-PAGE, and blotted onto a nitrocellulose 
membrane, which was then saturated with skimmed 
milk and incubated with antibodies against αSMA 
(Abcam, cat. No. ab32575), lumican (Abcam, cat. No. 
ab168348), Fn (Abcam, cat. No. 6328) or GAPDH 
(Cell Signaling, cat. No. 2118) overnight at 4°C. The 
next day membranes were incubated with the respective 
peroxidase-labeled secondary antibodies (Amersham, 
GE Healthcare, Illinois, USA, Cat. No. NA934V) for 
1h at room temperature. The peroxidase signal was then 
developed by chemiluminescence (ECL SuperSignalTM 
West Dura Extended Duration Substrate, Thermo Fisher 
Scientific, Massachusetts, USA, Cat. No. 34075) and 
revealed with the ChemiDocTM Touch Imaging System 
(BIORAD, Hercules, California, USA). Signal intensity 
was quantitated by the Image-J Software [13]. 
2.4 Immunofluorescence
The expression pattern of Lumican and αSMA was 
investigated by immunofluorescence staining of HK 
grown on coverslips coated with collagen and Fn in 24 
well plates at a cell density of 5.000 cells/cm2. The next 
day, cells were starved 4 hours in serum free medium 
(SFM), and then incubated for 3 hours with Mix1 or 
left in SFM. TGFβ1 (Sigma-Aldrich) was added at 
10 ng/ml, and cells incubated for further 48 hours. 
At the end of the incubation period, cell monolayers 
were rinsed three times with PBS and fixed with 4% 
paraformaldehyde for 15 minutes at room temperature. 
Subsequently, cells were incubated for 30 minutes at 
room temperature in blocking solution (0.1% Triton 
in PBS with 0.5% bovine serum albumin (BSA)) and 
incubated overnight with primary polyclonal antibodies 
diluted 1:500 in blocking solution: anti-αSMA (Abcam, 
cat. No. ab32575) or anti-lumican (Abcam, cat. No. 
ab168348). The next day, cells on coverslips were 
washed 3 times in PBS before adding the secondary 
antibody diluted 1:1000 in blocking solution (Alexa 
Fluor 488 AffiPure Goat Anti-Rabbit IgG, cat. No. 
111-545-045) for 1 hour at room temperature. After 
further washings in PBS, nuclei were counterstained 
with Hoechst 33342 (Invitrogen, cat. No. H3570) 
diluted 1:5000 in PBS and incubated for 4 minutes 
at room temperature. Cell fluorescence was detected 
with a Leica TCS SP 8 AOBS confocal laser scanning 
microscope.
2.5 Statistics
All experiments have been run in triplicates and 
repeated at least three times. One-way ANOVA followed 
by Tukey’s test was used to evaluate the statistical 
significance of each experimental group. Differences with 
P value < 0.05 were considered statistically significant. 
All data are expressed as the mean ± standard deviation. 
All statistical analyses were conducted with the GraphPad 
PRISM statistical software package version 5.00 for 
Windows (GraphPad Software, San Diego, CA USA).
3. Results
3.1 Effects of Different Molecules on the Expression 
of Lumican and αSMA on Human Keratocytes
Human primary keratocytes kept in cell culture with 2% 
FBS express more lumican than αSMA, as expected by 
normal keratocytes in a healthy corneal stroma. However, 
we observed a variable ratio lumican/αSMA between 
1.25 (Figure 1C) and 1.8 (Figure 2C) due to an increased 
expression of αSMA with senescence. Likely, also the 
presence of FBS - even though at low concentration - 
during routinary tissue culture might have contributed 
toward this progressive shift, as it is known that the 
keratocyte phenotype is better preserved under serum-
free conditions [14]. The effect of the addition to the culture 
medium of different molecules chosen after a screening 
of several more, based on their influence on the ratio 
lumican/αSMA, is also shown in Figure 1. Vitamins A 
and E, SL and HA at the concentrations used had no effect 
on cell viability (not shown). Vitamin E at 50 μM and 
Vitamin A at 10 μM had opposite effects on the lumican/
αSMA ratio since it was slightly decreased by Vitamin E 
and slightly increased by Vitamin A (Figure 1C). SL 2% 
enhanced lumican expression, almost doubling its ratio 
to αSMA, while HA had no detectable effect (Figure 
1C). The association of all four (Mix 1) or of vitamins 
only (Mix 2) had the net result of enhancing lumican 
expression (Figure 1B) and therefore also the ratio 
lumican/αSMA (Figure 1C).
3.2 Effects of TGFβ on the Ratio Lumican/αSMA 
is Countered by Each Molecule, either Alone or in 
Association
Treatment for 48 hours of HK cells with TGFβ (10 
ng/ml) triggered a 50% enhanced expression of αSMA 
DOI: https://doi.org/10.30564/jim.v10i2.3382 
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and a 70% decreased expression of lumican (Figure 2), 
characteristic of the transition keratocyte-myofibroblast, 
as expected [7-8]. The simultaneous presence with TGFβ of 
any of the molecules illustrated above was able to prevent 
such transition (Figure 2A), as indicated by the reduced 
changes observed on αSMA and lumican. Every molecule 
was able to normalize the levels of αSMA and to prevent 
the decrease of lumican expression (Figure 2B), so that 
the ratio lumican/αSMA, although still lower than control 
cells, was significantly higher than TGFβ-only treated 
cells (Figure 2C). Both associations (Mix 1 and Mix 2) 
returned a ratio lumican/αSMA clearly in favor of lumican 
(Figure 2C), although with a different effect on the single 
components (Figure 2B). In fact, Mix 1 strongly reduced 
the effects on αSMA (which was even lower than in control) 
with a lesser effect on the decrease of lumican, while Mix 
2 maintained lumican expression at control levels, while 
slightly decreasing αSMA expression. However, the overall 
effect on their ratio was comparable (Figure 2C).
3.3 Immunofluorescence Staining of Human 
Keratocytes for Lumican and αSMA Indicates a 
Phenotypic Shift, Countered by the Association of 
All Four Molecules (Mix1)
Figure 3A shows by immunofluorescence labeling 
of HK the decreased intensity of lumican after TGFβ 
treatment, and how Mix 1 (the most effective among the 
two, including all 4 components) was able to preserve 
lumican expression. On the contrary, αSMA expression 
was enhanced by TGFβ (Figure 3B), with HK showing 
a more elongated phenotype, with long stress fibers of 
αSMA. The presence of Mix 1 prevented the increase of 
αSMA and the morphological shift. 
3.4 Enhancement of Fn Expression by TGFβ is 
Prevented by Each Molecule either Alone or in 
Association
Among the changes induced in keratocytes by TGFβ 
Figure 1. Effect of different molecules on the expression of lumican and αSMA in HK (passage 8). A: HK were grown 
in SFM for 48 hours in the presence of each compound at the indicated concentration. Thirty μg of proteins were loaded 
on a 4-20% SDS-PAGE, and specific bands revealed by the respective antibodies. B: Densitometry analysis of each 
band (lumican or αSMA) is reported with respect to GAPDH as arbitrary units (a.u.). C: Ratio of lumican vs. αSMA 
derived from the densitometric analysis shown in B (actual numbers are shown at the bottom of each bar).
* p < 0.05 vs. control.
HK: Human Keratocytes; SMA: Smooth Muscle Actin; SFM: Serum Free Medium; SDS-PAGE: Sodium Dodecylsulphate-
Polyacrylamide-Gel-Electrophoresis; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase.
DOI: https://doi.org/10.30564/jim.v10i2.3382 
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Figure 2. Effect of different molecules on the expression of lumican and αSMA in HK (passage 3) treated with TGFβ1. A: 
HK were pre-treated for 3 hours with each molecule at the indicated concentration; then TGFβ1 (10 ng/ml) was added, 
and incubation continued for further 48 hours. Thirty μg of proteins were loaded on a 4-20% SDS PAGE, and specific 
bands revealed by the respective antibodies. B: Densitometry analysis of each band (lumican or αSMA) is reported 
with respect to GAPDH as arbitrary units (a.u.). C: Ratio of lumican vs. αSMA derived from the densitometric analysis 
shown in B (actual numbers are shown at the bottom of each bar).
* p < 0.05 vs. control; § p < 0.05 vs. TGFβ
HK: Human Keratocytes; SMA: Smooth Muscle Actin; SFM: Serum Free Medium; SDS-PAGE: Sodium Dodecylsulphate-
Polyacrylamide-Gel-Electrophoresis; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; TGF: Transforming Growth Factor. 
Figure 3. Immunofluorescence analysis of lumican and αSMA in HK (passage 3) treated with TGFβ1 (10 ng/ml) in the 
presence or absence of the association of the four compounds (Mix 1). A: lumican expression is decreased by TGFβ 
treatment, and conserved in the presence of Mix 1; B: αSMA expression is increased by TGFβ1 treatment, where also a 
morphological change is apparent, while Mix 1 blunted both effects of TGFβ1.
HK: Human Keratocytes; SMA: Smooth Muscle Actin; SFM: Serum Free Medium; TGF: Transforming Growth Factor. 
DOI: https://doi.org/10.30564/jim.v10i2.3382 
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treatment, Fn expression is known to be enhanced [14]. 
Therefore, we evaluated how Fn expression was modulated 
in this human keratocyte cell line by the different molecules 
in the presence or in the absence of TGFβ (Figure 4). In 
the absence of TGFβ, Fn expression was doubled by HA 
treatment, while the association of the four components 
(Mix 1) resulted in a 50% decrease (Figure 4A-C). Addition 
of TGFβ (10 ng/ml) to the cell culture resulted in a 100% 
increase of Fn expression (Figure 4B-D). The simultaneous 
presence of each single molecule was already enough to 
prevent such increase. The presence of the Mix 1 further 
decreased Fn expression by 50% despite the presence 
of TGFβ, while the association of the vitamins A and E 
alone (Mix 2) only partially prevented the increase of Fn 
expression, which however remained at levels higher than 
the control.
4. Discussion
We have shown in this paper a basic proof of concept 
that an association of natural molecules at nontoxic 
concentrations may have the ability to counteract the 
consequences of an inflammatory state of the cornea 
which, through the action of TGFβ, leads to keratocytes 
transdifferentiation, alterations of corneal stroma, and 
finally to corneal opacification (corneal haze).
Corneal stroma keratocytes produce a specific and 
balanced population of proteoglycans (lumican, keratocan, 
mimecan, decorin), the arrangement of which is essential 
for corneal transparency [15]. Among these, lumican 
seems to be the main orchestrator in order to produce and 
maintain a regular structure of corneal stroma, which is an 
essential requisite for transparency. Lumican is a keratan 
sulfate (KS) proteoglycan belonging to the small leucine 
rich proteoglycan family (SLRP). SLRPs contain a protein 
core modified by glycosaminoglycans side chains, which 
confer them their specific properties in the regulation 
of tissue-specific matrix assembly, and mediating cell-
matrix interactions [16]. Preclinical studies have indicated 
a role for lumican in the pathogenesis of different ocular 
diseases such as glaucoma, myopia, inflammatory eye 
diseases and wound healing [17]. A prominent role of 
lumican in the corneal stroma is the regulation of collagen 
fibrils assembly [18]. Mice made homozygous for a null 
mutation in lumican show collagen fibril abnormalities in 
Figure 4. Effect of different molecules on the expression of fibronectin in human keratocytes (passage 5) with or 
without TGFβ1 treatment. A: HK were grown in SFM for 48 hours in the presence of each compound at the indicated 
concentration. Thirty μg of proteins were loaded on a 4-20% SDS PAGE, and specific bands (Fn or GAPDH) revealed 
by the respective antibodies. B: HK were pre-treated for 3 hours with each molecule at the indicated concentration; then 
TGFβ1 (10 ng/ml) was added, and incubation continued for further 48 hours. Thirty μg of proteins were loaded on a 4-20% 
SDS PAGE, and specific bands (Fn or GAPDH) revealed by the respective antibodies. C and D: Densitometry analysis of Fn 
is reported with respect to GAPDH as arbitrary units (a.u.) (actual numbers are shown at the bottom of each bar).
* p < 0.05 vs. control; § p < 0.05 vs. TGFβ
HK: Human Keratocytes; SMA: Smooth Muscle Actin; SFM: Serum Free Medium; SDS-PAGE: Sodium Dodecylsulphate-
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the posterior stroma, where collagen is more abundant, 
finally resulting in a 25% reduction in KS content, a 
40% reduction of stromal thickness and bilateral corneal 
opacification [19]. Differently, null mice for keratocan 
(another cornea specific KS proteoglycan) show a 
less severe corneal phenotype, with a thinner, but still 
transparent cornea [20,21]. Indeed, it is known that mutated 
keratocan may result in changes of corneal curvature, 
and thus its refraction ability, but no significant collagen 
fibril structural defects [22]. On the other hand, lumican 
overexpression in corneas of wild type mice also resulted 
in no alteration of collagen organization and corneal 
transparency, however it decreased corneal keratocan 
expression, thus indicating a regulatory role of lumican 
for keratocan expression [23]. Moreover, lumican contains 
an aminoacid sequence endowed with self-assembling 
properties, and able to stimulate collagen biosynthesis [24,25].
αSMA is a cytoskeletal protein typical of muscle 
cells. Expression of αSMA in fibroblasts or keratocytes 
(during their transition to myofibroblasts) may happen 
during wound healing since wound closure is facilitated 
by the contractile properties and higher motility of these 
myofibroblasts [26,27]. The production of αSMA is linked 
to the presence of Fn in the basement membrane because 
its synthesis is enhanced by the interaction of Fn with its 
integrin receptor [28]. 
Therefore, in keratocytes, the ratio lumican/αSMA 
and the amount of Fn produced are indicative of the 
differentiation state of the cells: a predominance of 
lumican over αSMA, and low levels of Fn production 
suggest a well differentiated state, whereas a decrease of 
lumican/αSMA ratio because of an increased production 
of αSMA and Fn indicate a degree of transdifferentiation. 
We report here that primary human keratocytes in tissue 
culture can indeed maintain a differentiated state with a 
ratio lumican/αSMA > 1 (Figure 1 and Figure 2), and low 
levels of Fn production (Figure 4), which can be basically 
modulated by the addition of some natural compounds, 
either isolated or mixed together.
Transforming growth factor-β (TGFβ) is a pleiotropic 
cytokine that regulates a myriad of cellular processes 
and has important roles in morphogenesis, embryonic 
development, adult stem cell differentiation, immune 
regulation, wound healing and inflammation [29]. In the 
eye, it has been found to be induced after PRK to regulate 
wound healing and keratocytes transdifferentiation, 
thus triggering corneal opacification [30]. TGFβ was 
found to regulate cell phenotype and induce epithelial-
mesenchymal transition in cancer cells, thus enhancing 
their invasive and metastatic ability, through the 
mechanistic target of rapamycin (mTOR) pathway [30]. 
The same trigger and pathway is also involved in the 
transdifferentiation keratocytes-myofibroblasts after PRK 
[31]. Rapamycin, a known inhibitor of the mTOR pathway 
[31,32], can thus prevent the transdifferentiation and also the 
consequent corneal haze [31]. 
Our data show indeed that TGFβ treatment resulted in 
decreased lumican expression and a parallel increase of 
both αSMA and Fn, so that the ratio lumican/αSMA was 
dramatically decreased (Figure 2).
Different strategies have been published aimed at 
preventing the keratocyte/myofibroblast transition. 
The only clinical intervention allowed nowadays 
consists in topical application of mitomycin C, which, 
by its genotoxic activity, inhibits the proliferation of 
myofibroblast progenitor cells, and thereby inhibits mature 
myofibroblasts generation [11]. It is an effective treatment 
[33], even though there is no unanimous consensus on 
the treatment protocol [34]. Among alternative treatments 
under investigation, rapamycin has been shown to work 
efficiently in a preclinical setting [32], also after topical 
application as eye drops [35], but no clinical data have 
been reported so far. Onion extract, due to its flavonoid 
content, can also reduce scar formation by inhibiting 
fibroblasts metabolism [36], and has shown its efficacy also 
in a dermatologic clinical setting [37]. Topical application 
as eye drops on canine eyes subjected to PRK were shown 
to prevent αSMA increase in keratocytes, and significantly 
reduced corneal haze formation [38]. 
We now show evidence that an association of vitamins 
A and E with SL and HA can also prevent TGFβ-induced 
expression changes of lumican, αSMA and Fn, typical 
of the transdifferentiation of keratocytes. Vitamin A 
deficiency in humans (and in mammals in general) can 
lead to alterations of the corneal epithelium (designated 
as xerophthalmia) characterized by opacification and 
keratinization [39] and dependent on the inactivation of the 
Notch1 pathway [40]. The efficiency of corneal proteinases 
also depends on a correct supply of vitamin A, the 
deficiency of which can lead to decreased exfoliation of 
epithelial cells, increased levels of keratofibrils in corneal 
keratocytes, increased stromal keratocyte degradation and 
increased susceptibility towards ulceration [41]. However, 
a clinical study designed to evaluate the efficacy of a 
topical perioperative supplementation of vitamin A (250 
IU per gram of ointment) in patients undergoing PRK 
found no significative effects on re-epithelialization time, 
postoperative pain, corneal haze formation, or visual 
outcomes after PRK [42]. On the contrary, a high dose oral 
supplementation of vitamin A and E (25 000 IU retinol 
palmitate and 230 mg alpha tocopheryl nicotinate) to 
patients scheduled to receive PRK treatment resulted in 
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accelerated re-epithelialization time and reduced corneal 
haze formation [43]. These latter results are consistent with 
our results shown in Figures 2 and 3 in which treatment of 
HK with vitamins A and E either isolated or in association 
(Mix 2) in the presence of TGFβ was already able to 
counteract its effects on the expression of lumican, 
αSMA and Fn, and likely on the transdifferentiation of 
keratocytes.
We had already shown that topical instillation of SL, 
either alone or in association with HA, is able to exert 
an antinflammatory effect on the cornea, preventing 
the increase of TGFβ and matrix metallopeptidase 
9 (MMP9) induced by inf lammatory agents  [44]. 
Consistently, in a rabbit model of PRK the instillation of 
HA eye drops inhibited subepithelial haze by favoring 
a more physiologic wound healing [45], likely due to the 
interaction of HA with its cellular receptor CD44, shown 
to be involved in rabbit corneal epithelial wound healing 
[46]. Our data here illustrated further support a role for 
HA in corneal healing after the wound caused by the 
PRK procedure, because just by itself it can limit the 
changes in lumican, αSMA and Fn expression induced by 
TGFβ (Figure 2 and 4), and in association with the other 
compounds shows an even better conservative ability 
(Figure 2 B). Similar results are also obtained with SL 
(Figure 2 and 4), showing for the first time its ability to 
influence keratocyte transdifferentiation and their response 
to inflammatory events.
In conclusion, we have shown here the respective 
efficacy of vitamins A and E, HA and SL either alone 
or in association to contrast the shift in the expression 
of keratocyte transdifferentiation markers such as 
lumican, αSMA and Fn induced by the pro-inflammatory 
cytokine TGFβ, likely the main responsible of keratocyte 
transdifferentiation and corneal opacification after PRK. 
Morphological changes induced by TGFβ could also be 
prevented by the association of the 4 compounds (Figure 
3). We are now investigating the molecular pathways 
involved in this shift, and how the different molecules 
here tested can interfere with them, and prevent the 
transdifferentiation and the corneal haze. Also, the 
efficacy of such formulation in a rabbit model system of 
corneal haze will be verified.
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